Cargando…
Immune Checkpoint Inhibitors and Their Cardiovascular Adverse Effects
Immune checkpoint inhibitors (ICIs) have reshaped and have become a well-established treatment modality for multiple advanced-stage malignancies. ICIs block the immune system regulatory checkpoints, namely CTLA-4 and PD-1/PDL1, which provokes excess immune response against self-antigens. Immune modu...
Autores principales: | Paluri, Ravi Kumar, Pulipati, Yochitha, Regalla, Dileep Kumar Reddy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691592/ https://www.ncbi.nlm.nih.gov/pubmed/38045806 http://dx.doi.org/10.3389/or.2023.11456 |
Ejemplares similares
-
Therapeutic options for ampullary carcinomas. A review
por: Regalla, Dileep Kumar Reddy, et al.
Publicado: (2019) -
Predictors and Adverse Outcomes of Acute Kidney Injury in Hospitalized Renal Transplant Recipients
por: Hod, Tammy, et al.
Publicado: (2023) -
Angiogenesis, Metabolism, Endothelial and Platelet Markers in Diabetes and Cardiovascular Disease
por: Blann, A. D., et al.
Publicado: (2022) -
Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
por: Ivulich, Steven, et al.
Publicado: (2023) -
Performance of Scores Predicting Adverse Outcomes in Procurement Kidney Biopsies From Deceased Donors With Organs of Lower-Than-Average Quality
por: Scurt, Florian G., et al.
Publicado: (2023)